Search
CN-201
go.drugbank.com/drugs/DB18726InvestigationalCN-201 is a humanized anti-CD3/CD19 bispecific antibody.
GB1211
go.drugbank.com/drugs/DB17499InvestigationalGB1211 is an orally active galectin-3 (Gal-3) inhibitor.
Isoliquiritigenin
go.drugbank.com/drugs/DB03285ExperimentalIsoliquiritigenin is a precursor to several flavonones in many plants.
Synonyms: (E)-1-(2,4-Dihydroxy-phenyl)-3-(4-hydroxy-phenyl)-propenone, (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propene-1-oneClorgiline
go.drugbank.com/drugs/DB04017ExperimentalAn antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
Gam-COVID-Vac
go.drugbank.com/drugs/DB15848InvestigationalJune 2020, and were completed in early August 2020. … Gam-COVID-Vac was created by Gamaleya Research Institute of Epidemiology and MIcrobiology in Russia.
Dirlotapide
go.drugbank.com/drugs/DB11399InvestigationalVet approvedDirlotapide is a drug employed in the treatment of obesity in dogs. It is marketed by Pfizer and Zoetis under the brand name, _Slentrol_, and is not intended for human use.
Peginterferon lambda-1a
go.drugbank.com/drugs/DB14767InvestigationalPeginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C). … Peginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs.
PF-06260414
go.drugbank.com/drugs/DB15221InvestigationalPF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects
Vocimagene amiretrorepvec
go.drugbank.com/drugs/DB15331InvestigationalVocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca
Tuspetinib
go.drugbank.com/drugs/DB15343InvestigationalTuspetinib (HM-43239) is under investigation in clinical trial NCT03850574 (Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed
Synonyms: 2-Pyrimidinamine, 5-chloro-N-(3-cyclopropyl-5-(((3R,5S)-3,5-dimethyl-1-piperazinyl)methyl)phenyl)-4-(6-methyl-1H-indol-3-yl)-, rel-, 5-Chloro-N-(3-cyclopropyl-5-(((3R,5S)-3,5-dimethylpiperazine-1-yl) methyl) phenyl)-4-(6-methyl-1hindol-3-yl) pyrimidin-2-amine